Local charity Life Cycle has been supporting Bristol residents to cycle for many years, teaching them the skills and confidence they need to get cycling. In a move to help even more people get on bikes, Life Cycle teamed ...
Sep 25, 2018
0
7
In a rare study of its kind, new University of Toronto research has identified how vitamin D3 and periodontitis influence Type 2 diabetes.
Aug 20, 2018
0
29
(HealthDay)—For patients with type 2 diabetes, absent dorsalis pedis and/or posterior tibial pulses are associated with increased risk of major vascular outcomes, according to a study published online Sept. 27 in Diabetes ...
Oct 4, 2016
0
0
(HealthDay)—Two new diabetes treatments, Tresiba (insulin degludec injection) and Ryzodeg (insulin degludec/insulin aspart injection), have been approved by the U.S. Food and Drug Administration.
Sep 29, 2015
0
8
Emerging evidence ties endocrine-disrupting chemical exposure to two of the biggest public health threats facing society - diabetes and obesity, according to the executive summary of an upcoming Scientific Statement issued ...
Sep 28, 2015
4
4251
Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications, a study shows, making the Type 2 diabetes medication the first shown to lengthen diabetics' lives.
Sep 17, 2015
0
12
Insensitivity to insulin, also called insulin resistance, is associated with type 2 diabetes and affects several cell types and organs in the body. Now, scientists from Sweden's Karolinska Institutet have discovered a mechanism ...
Sep 17, 2015
0
13
A three-year-old who tipped the scales at 35 kilograms (77 pounds) has become one of the youngest people ever diagnosed with a lifestyle-related form of diabetes that strikes adults, her doctor said Thursday.
Sep 17, 2015
0
27
New research presented at this year's annual meeting of the European Association for the Study of Diabetes (EASD) in Stockholm shows that high consumption of sugar-sweetened beverages, which has been linked to increased risk ...
Sep 16, 2015
1
7
Drugmaker Merck & Co. says its experimental Type 2 diabetes drug performed about as well as its older daily pill, Januvia, in a late-stage patient test.
Sep 16, 2015
0
5
